Organogenesis Holdings Inc expected to post a loss of 6 cents a share - Earnings Preview

Organogenesis Holdings

05/08/2025 23:40

Organogenesis Holdings Inc ORGO.OQ ORGO.O is expected to  show a fall in quarterly revenue when it reports  results on August 7 for the period ending June 30 2025

The Canton Massachusetts-based  company is expected to report a 20.6% decrease in revenue to $103.4 million from $130.23 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.The company's guidance on May 8 2025, for the period ended June 30, was for revenue between $100.00 million and $110.00 million.

​LSEG's mean analyst estimate for Organogenesis Holdings Inc is for a loss of 6 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Organogenesis Holdings Inc is $7.00, about 35.3% above its last closing price of $4.53

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.06
-0.06
-0.10
Missed
-76.5
Dec. 31 2025
0.00
-0.01
0.06
Beat
580
Sep. 30 2024
-0.02
-0.01
0.09
Beat
700​
Jun. 30 2024
0.00
0.00
0.04
Beat
​​Mar. 31 2024
-0.03
-0.03
-0.02
Beat
25
Dec. 31 2023
0.01
0.01
0.00
Missed
-100​
Sep. 30 2023
0.00
0.01
0.02
Beat
300
Jun. 30 2023
0.02
0.03
0.04
Beat
60

This summary was machine generated August 5 at 22:40 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)